Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590889 · ClinicalTrials.gov registry record · NA
Artificial Valve Endocarditis Reduction Trial
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 807
- Enrollment target
NCT00590889 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 807 participants.
The verdict
NCT00590889, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 807 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether the Silzone coated sewing cuff reduces the incidence of prosthetic valve endocarditis (PVE).
Interventions
- DEVICE Artificial Mechanical Heart Valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 807 participants |
| Start Date | 1998-07 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00590889
The ClinicalTrials.gov registry entry for NCT00590889 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 807 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Artificial Mechanical Heart Valve is the first listed.
NCT00590889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00590889 about?
NCT00590889 is a clinical study titled "Artificial Valve Endocarditis Reduction Trial". The purpose of this study is to investigate whether the Silzone coated sewing cuff reduces the incidence of prosthetic valve endocarditis (PVE).
What is the current status of trial NCT00590889?
This trial is currently terminated. It is a NA study. The enrollment target is 807 participants. The study started on 1998-07. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00590889?
The interventions under investigation include: Artificial Mechanical Heart Valve (DEVICE).
Who is sponsoring clinical trial NCT00590889?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.